Vimarsana
Biggest News Aggregation in the World

Luke Evnin News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Luke Evnin. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Luke Evnin Today - Breaking & Trending Today

The Scleroderma Research Foundation Appoints Dr. Gregory Gordon as Chief Medical Officer - Vimarsana News

The Scleroderma Research Foundation Appoints Dr. Gregory Gordon as Chief Medical Officer

/PRNewswire/ -- The Scleroderma Research Foundation (SRF)— the nation's largest non-profit funder of scleroderma research—announces the appointment of Gregory...

The Scleroderma Research Foundation Announces the Launch of the CONQUEST Trial Platform and IND Clearance - Vimarsana News

The Scleroderma Research Foundation Announces the Launch of the CONQUEST Trial Platform and IND Clearance

/PRNewswire/ -- The Scleroderma Research Foundation (SRF), the nation's largest non-profit funder of scleroderma research, today announced that the FDA has...

Kyverna's CAR T-Cell Therapy Expands Autoimmune Investigations Into Myasthenia Gravis - Vimarsana News

Kyverna's CAR T-Cell Therapy Expands Autoimmune Investigations Into Myasthenia Gravis

The therapy is already being evaluated in patients with lupus nephritis and diffuse cutaneous systemic sclerosis.

Source: ajmc.com
Bob Saget Remembered at Scleroderma Research Foundation Event - Vimarsana News

Bob Saget Remembered at Scleroderma Research Foundation Event

Caroline Hirsch was honored with the first ever Bob Saget Legacy Award during the event, which raised $1.2 million for scleroderma research.

The Scleroderma Research Foundation (SRF) Announces Second Partnership for Conquest Trial Platform - Vimarsana News

The Scleroderma Research Foundation (SRF) Announces Second Partnership for Conquest Trial Platform

/PRNewswire/ -- The Scleroderma Research Foundation (SRF), the nation's largest non-profit funder of scleroderma research, today announced that Boehringer...